Optum and Takeda executives discuss their efforts to collaborate on implementing a value-based care for people with ...

The growth in spending on the glucagon-like peptide 1 (GLP-1) agonists is a “mega tsunami,” said Doug Long, MBA, vice ...

Johns Hopkins researchers have shown that a monoclonal antibody can reverse type 1 diabetes. It targets a different antigen ...

The rate of ketoacidosis among children younger than 5 years of age with type 1 diabetes is higher in Medicaid than ...

The role macrophages play in the development of pulmonary fibrosis, which impacts as many as 100,000 U.S. citizens a year, ...

The growth in spending on the glucagon-like peptide 1 (GLP-1) agonists is a “mega tsunami,” said Doug Long, MBA, vice president industry relations for IQVIA. The script that specialty drugs are the ...

In an interview before the Asembia meeting, Luke Greenwalt, MBA, vice president, market access for IQVIA, discussed the hot ...

Understanding how physician sex contributes to these disparities is crucial as evidence on the impact of physician sex on ...

How the Inflation Reduction Act is implemented and the role of pharmacy benefit managers in drug pricing are likely to be two ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Cencora’s Corey Ford says after the IRA’s out-of-pocket cap goes into effect next year, Part D plans are expected to put in ...

Tasmina Hydery, Pharm.D., MBA, associate director, digital solutions, Cencora, spoke with MHE editors about the slow uptake ...